Page last updated: 2024-09-03

rc 3095 and Adenocarcinoma, Clear Cell

rc 3095 has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arencibia, JM; Chatzistamou, I; Groot, K; Hebert, F; Schally, AV; Szepeshazi, K	1

Other Studies

1 other study(ies) available for rc 3095 and Adenocarcinoma, Clear Cell

Article	Year
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix. Cancer letters, 2001, Sep-28, Volume: 171, Issue:1 Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents, Hormonal; Bombesin; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gene Expression Regulation, Neoplastic; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Mice; Mice, Nude; Neoplasm Proteins; Ovarian Neoplasms; Peptide Fragments; Receptors, Bombesin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Specific Pathogen-Free Organisms; Xenograft Model Antitumor Assays	2001

Article

Year

Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.

Cancer letters, 2001, Sep-28, Volume: 171, Issue:1

Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents, Hormonal; Bombesin; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gene Expression Regulation, Neoplastic; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Mice; Mice, Nude; Neoplasm Proteins; Ovarian Neoplasms; Peptide Fragments; Receptors, Bombesin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Specific Pathogen-Free Organisms; Xenograft Model Antitumor Assays

2001